Status | Study |
RECRUITING |
Study Name: AMX0035 and Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2023-11-03 Interventions: Proprietary formulation of sodium phenylbutyrate and taurursodiol |
Recruiting |
Study Name: Study of BMS-986168 in Patients With Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2017-02-27 Interventions: Biological: BMS-986168 BMS-986 |
Recruiting |
Study Name: A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2016-12-01 Interventions: Drug: ABBV-8E12 ABBV-8E12 (20 |
Recruiting |
Study Name: Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy (PSP) Date: 2016-06-30 Interventions: Drug: Rivastigmine Drug: Placebo |
Completed |
Study Name: Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Parkinson's Disease Date: 2016-03-31 Interventions: Device: active Deep TMS |
Enrolling by invitation |
Study Name: Extension Study of BMS-986168 in Patients With Progressive Supranuclear Palsy Who Participated in CN002003 Condition: Progressive Supranuclear Palsy Date: 2016-01-13 Interventions: Drug: BMS-986168 Same dose as corresponding CN002003 study panel. |
Recruiting |
Study Name: A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2015-11-03 Interventions: Drug: F-18 AV 1451 Tau PET scan Other Name: Tau bind |
Active, not recruiting |
Study Name: Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2015-06-30 Interventions: Drug: Single dose C2N-8E12 C2N |
Active, not recruiting |
Study Name: Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2015-05-20 Interventions: Drug: BMS-986168 Drug: Placebo |
Recruiting |
Study Name: Young Plasma Transfusions for Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2015-05-19 Interventions: Other: Fresh Frozen Plasma Fresh Frozen Plasma [young (<30 years of age) healthy male donors] Solutio |